Press release
Antiobesity Drugs Market Segmentation Report 2020: Demand, Trends, Opportunities, Strategies, Challenges And Forecast To 2022
The global antiobesity market was valued at about $1.3 billion in 2018 and is expected to grow to $3.44 billion at a CAGR of 27.5% through 2022.
Place a DIRECT PURCHASE ORDER of The Entire 140+ Pages Report @
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2449
The anti-obesity drugs market consists of sales of anti-obesity drugs and related services. This industry includes establishments that produce pharmacological agents that reduce or control overweight.
Pharmaceutical industry is witnessing an increase in the number of mergers and acquisition among companies developing drugs for metabolic disorders such as obesity, diabetes and others. This is a strategy of pharmaceutical companies to strengthen their drug portfolio in metabolic diseases and launch safe and effective drugs in the market.
Antiobesity Drugs Market Segmentation: -
By Drug Class
1) Peripherally acting anti obesity drugs
2) Centrally acting anti obesity drugs
Browse Complete Report @
https://www.thebusinessresearchcompany.com/report/antiobesity-drugs-global-market-report
By Type
1) Prescription Drugs (Rx)
2) OTC Drugs
Few Points From Table Of Content
1. Executive Summary
2. Anti-obesity Drugs Market Characteristics
3. Anti-obesity Drugs Market Size And Growth
4. Anti-obesity Drugs Market Segmentation
5. Anti-obesity Drugs Market Regional And Country Analysis
……
25. Anti-obesity Drugs Market Competitive Landscape And Company Profiles
26. Key Mergers And Acquisitions In The Anti-obesity Drugs Market
27. Anti-obesity Drugs Market Trends And Strategies
28. Product Pipeline Analysis
29. Anti-obesity Drugs Market Future Outlook and Potential Analysis
30. Appendix
The report covers the trends and market dynamics of the anti-obesity drugs market in major countries - Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA. The report also includes consumer surveys and various future opportunities for the market.
Request for a Sample Copy of This Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=2449&type=smp
Some of the key players involved in the anti-obesity drugs market are F. Hoffmann-La Roche AG, , GlaxoSmithKline PLC, , Boehringer Ingelheim GmbH, and Pfizer Inc
Contact Information:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on Blog: http://blog.tbrc.info/
About US:
The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets after WHO declared COVID-19 as a pandemic.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antiobesity Drugs Market Segmentation Report 2020: Demand, Trends, Opportunities, Strategies, Challenges And Forecast To 2022 here
News-ID: 2178083 • Views: 323
More Releases from The Business research company
Avocado Market size and Forecast 2023-2032 | Industry overview, latest Trend and …
Avocado Market Size, Growth Rate, And Forecast:
The global avocado market size is expected to grow from $13.81 billion in 2022 to $15 billion in 2023 at a compound annual growth rate (CAGR) of 8.6%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge…
Analysis Of Key Market Opportunities And Growth Trends In The Minimal Residual D …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
Minimal Residual Disease Testing Market Size, Growth Rate, And Forecast
The global minimal residual disease testing market size is expected to grow from $1.22 billion in 2022 to $1.41 billion in 2023 at a compound annual growth rate (CAGR) of 14.7%. The Russia-Ukraine war disrupted the chances of…
Global Methane Market Growth Prospects, Future Industry Landscape 2032 | BP Plc. …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
Methane Market Size, Growth Rate, And Forecast
The global methane market size is expected to grow from $97.06 billion in 2022 to $106.65 billion in 2023 at a compound annual growth rate (CAGR) of 9.9%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19…
Jet Fuel Market 2023 Latest Insights, Growth Rate, Future Trends And Forecast | …
The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032
Jet Fuel Market Size, Growth Rate, And Forecast
The global jet fuel market size is expected to grow from $186.30 billion in 2022 to $195.98 billion in 2023 at a compound annual growth rate (CAGR) of 5.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
